ARTICLE | Company News

Human Genome Sciences, U.S. Department of Health and Human Services infectious news

June 26, 2006 7:00 AM UTC

HHS exercised an option under a two-phase contract with HGSI to purchase 20,000 treatment courses of ABthrax raxibacumab anthrax vaccine for $165.2 million. HGSI expects to deliver ABthrax to the Str...